An international patient survey to identify candidate items for classifying early-stage symptomatic knee osteoarthritis
Lauren King, Armaghan Mahmoudian, Jean Liew, Quike Wang, Ian Stanaitis, Dieuwke Schiphof, Leigh F. Callahan, David Hunter, C. Thomas Appleton, Aleksandra Turkiewicz, …
Osteoarthritis and cartilage, Vol.32(Supplement 1), pp.S257-S258
Poster Abstracts from the 2024 OARSI World Congress on Osteoarthritis
2024 OARSI World Congress on Osteoarthritis (Vienna, Austria, 01/01/2024)
Purpose (the aim of the study): The Osteoarthritis Research Society International (OARSI) has launched an initiative to develop classification criteria for early-stage symptomatic knee osteoarthritis (EsSKOA). The goal is to establish a standardized way to identify and enrol individuals with symptomatic knee OA but without established or later-stage knee OA into clinical studies, i.e., at an earlier stage of symptomatic disease. The classification criteria must accurately discriminate individuals with EsSKOA both from individuals with other causes for their knee symptoms and individuals with established or later-stage knee OA. The first phase (item generation) seeks to generate a comprehensive list to consider for the classification of EsSKOA. To incorporate patient perspectives into the first phase, our objectives were to 1) develop a list of symptoms which, according to individuals living with knee OA, emerged within the first year of symptom onset; and 2) identify symptoms, signs and/or tests perceived to have helped them and their health professional(s) indicate their symptoms were due to knee OA and not another condition.
Related links
Details
Title
An international patient survey to identify candidate items for classifying early-stage symptomatic knee osteoarthritis
Publication Details
Osteoarthritis and cartilage, Vol.32(Supplement 1), pp.S257-S258
Resource Type
Abstract
Conference
2024 OARSI World Congress on Osteoarthritis (Vienna, Austria, 01/01/2024)
Publisher
Elsevier Ltd; United Kingdom
Series
Poster Abstracts from the 2024 OARSI World Congress on Osteoarthritis